S. Di Serio

发表

Multivariate analysis of behavioral aging highlights some unexpected features of complex systems organization.

L. Angelucci, O. Ghirardi, A. Caprioli, 1994, Behavioral and neural biology.

ST2472: a new potential antipsychotic with very low liability to induce side-effects.

G. Campiani, F. Borsini, M. A. Stasi, 2008, The international journal of neuropsychopharmacology.

Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).

F. Borsini, S. Pace, A. Caprioli, 2015, European journal of pharmacology.

Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.

Caterina Fattorusso, Giuseppe Campiani, Alfredo Cagnotto, 2004, Journal of medicinal chemistry.

2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.

Giovanni Piersanti, Fabrizio Giorgi, Giorgio Tarzia, 2005, Journal of medicinal chemistry.

Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.

S. Gemma, G. Campiani, S. Butini, 2005, Journal of medicinal chemistry.

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models

R. Coccurello, M. Maccarrone, V. Vacca, 2012, Journal of Pharmacology and Experimental Therapeutics.

Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.

M. Brindisi, S. Gemma, G. Campiani, 2012, Journal of medicinal chemistry.

An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain

V. Felipo, A. Ferrer-Montiel, O. Cauli, 2012, Journal of Pharmacology and Experimental Therapeutics.

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models

R. Coccurello, M. Maccarrone, V. Vacca, 2012, Journal of Pharmacology and Experimental Therapeutics.